3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
2
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Pancreatic Cancer Metastatic
1
Nasopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Renal Cell Carcinoma (RCC)
1
Advanced Malignant Solid Tumors
1
Advanced Lung Cancer
1
Advanced Breast Cancer
1
Interventions
Cisplatin
9
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Radiotherapy
5
Platinum
5
1,2-diaminocyclohexaneplatinum II citrate
5
Biopsy
4
Radiotherapy, Intensity-Modulated
3
Radiation
3
Nivolumab
3
Carboplatin
3
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Disulfides
2
Cetuximab
2
(225)Ac-DOTA-c(RGDyK)
2
pembrolizumab
1
niraparib
1
ipatasertib
1
durvalumab
1
dostarlimab
1
cemiplimab
1
cabozantinib
1
atezolizumab
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Taxes
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Radiotherapy, Image-Guided
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
toripalimab
×
30 days
×
Clear all
No trials found.